Primary testicular lymphoma: review


Autoria(s): Boujelbene N.; Ketterer N.; Boujelbene N.; Khanfir K.; Bhagwati S.; Herrmann E.; Mirimanoff R. O.; Ozsahin M.; Zouhair A.
Data(s)

2011

Resumo

Primary testicular lymphoma is a rare form of non-Hodgkin's lymphoma. It occurs more frequently in older patients, and it is a potentially lethal disease. For early stages (I and II), the management consists of orchidectomy followed by chemotherapy combined with monoclonal antibodies directed against the CD20 antigen and scrotal radiotherapy (sanctuary site) with/or without iliac and/or paraaortic lymph node radiotherapy. For advanced stages (III and IV), chemo-immunotherapy is the treatment of choice while scrotal radiotherapy can be discussed. Both in early or advanced disease, intrathecal chemotherapy is necessary to prevent central nervous system relapse. New molecular approaches and/or more aggressive treatments are to be explored in this rare disease. To cite this journal: Oncologie 13 (2011).

Identificador

http://serval.unil.ch/?id=serval:BIB_3A98870D16D4

isbn:1292-3818

doi:10.1007/s10269-011-2029-5

isiid:000295449600013

Idioma(s)

fr

Fonte

Oncologie, vol. 13, no. 9, pp. 598-604

Palavras-Chave #Testis; Lymphoma; Treatment; Radiotherapy; Chemotherapy; B-CELL LYMPHOMA; NON-HODGKINS-LYMPHOMA; CHEMOTHERAPY PLUS RITUXIMAB; ELDERLY-PATIENTS; CHOP CHEMOTHERAPY; TESTIS; MULTICENTER; TRIAL; EXPERIENCE; PROGNOSIS
Tipo

info:eu-repo/semantics/review

article